Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$87.72
-0.7%
$97.19
$81.97
$139.06
$153.94B0.6513.17 million shs8.52 million shs
Dover Corporation stock logo
DOV
Dover
$207.93
-1.4%
$214.58
$158.97
$237.54
$28.41B1.21937,278 shs912,174 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.74%+3.44%-5.50%-21.82%-34.09%
Dover Corporation stock logo
DOV
Dover
-1.31%-2.87%-5.69%-10.81%+16.41%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$87.72
-0.7%
$97.19
$81.97
$139.06
$153.94B0.6513.17 million shs8.52 million shs
Dover Corporation stock logo
DOV
Dover
$207.93
-1.4%
$214.58
$158.97
$237.54
$28.41B1.21937,278 shs912,174 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.74%+3.44%-5.50%-21.82%-34.09%
Dover Corporation stock logo
DOV
Dover
-1.31%-2.87%-5.69%-10.81%+16.41%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.4336.16% Upside
Dover Corporation stock logo
DOV
Dover
2.60
Moderate Buy$237.3614.15% Upside

Current Analyst Ratings Breakdown

Latest DOV and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingBuy$131.00
4/24/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C)Hold (C-)
4/24/2026
Dover Corporation stock logo
DOV
Dover
Reiterated RatingBuy
4/24/2026
Dover Corporation stock logo
DOV
Dover
Reiterated RatingHold$229.00
4/24/2026
Dover Corporation stock logo
DOV
Dover
Reiterated RatingSector Perform$252.00
4/24/2026
Dover Corporation stock logo
DOV
Dover
Boost Price TargetOutperform$242.00 ➝ $250.00
4/24/2026
Dover Corporation stock logo
DOV
Dover
Boost Price TargetEqual Weight$206.00 ➝ $230.00
4/24/2026
Dover Corporation stock logo
DOV
Dover
Boost Price TargetMarket Perform$237.00 ➝ $250.00
4/24/2026
Dover Corporation stock logo
DOV
Dover
Boost Price TargetOutperform$255.00 ➝ $279.00
4/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeOutperformNeutral$92.00
4/21/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$140.00 ➝ $125.00
(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$45.13B3.39$6.94 per share12.64$30.26 per share2.90
Dover Corporation stock logo
DOV
Dover
$8.09B3.46$12.25 per share16.98$55.62 per share3.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5724.5714.481.4713.90%17.62%10.01%7/16/2026 (Estimated)
Dover Corporation stock logo
DOV
Dover
$1.09B$8.0225.9318.271.6113.30%18.01%10.10%7/23/2026 (Estimated)

Latest DOV and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2026Q1 2026
Dover Corporation stock logo
DOV
Dover
$2.27$2.28+$0.01$1.75$2.19 billion$2.05 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.87%+10.39%70.59%54 Years
Dover Corporation stock logo
DOV
Dover
$2.081.00%+1.00%25.94%70 Years

Latest DOV and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2026
Dover Corporation stock logo
DOV
Dover
quarterly$0.520.95%5/29/20265/29/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Dover Corporation stock logo
DOV
Dover
0.35
1.87
1.32

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Dover Corporation stock logo
DOV
Dover
84.46%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Dover Corporation stock logo
DOV
Dover
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Dover Corporation stock logo
DOV
Dover
24,000134.66 million133.18 millionOptionable

Recent News About These Companies

Dover Announces 2026 Scholarship Program Winners
Dover Corporation Signals Strong Growth and AI Upside
Dover Declares Regular Quarterly Cash Dividend

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$87.72 -0.66 (-0.75%)
Closing price 05/21/2026 03:59 PM Eastern
Extended Trading
$87.95 +0.23 (+0.26%)
As of 05:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Dover stock logo

Dover NYSE:DOV

$207.93 -3.05 (-1.45%)
Closing price 05/21/2026 03:59 PM Eastern
Extended Trading
$213.84 +5.91 (+2.84%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The company's Engineered Products segment provides various equipment, component, software, solution, and services that are used in vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector; winches, hoists, bearings, drives, and electric monitoring system; and radio frequency and microwave filters and switches, and signal intelligence solutions. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe storage and transport of fuel, cryogenic gases, and hazardous fluids, as well as operation of retail fueling and vehicle wash establishment. The company's Imaging & Identification segment provides precision marking and coding, product traceability equipment, brand protection, and digital textile printing equipment and solution, as well as related consumable, software, and service to packaged and consumer goods, pharmaceutical, manufacturing, fashion and apparel, and other end-market. Its Pumps & Process Solutions segment manufactures specialty pump, connector, flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The company's Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.